Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Robert Plisko"'
Publikováno v:
Farmacja Polska, Vol 78, Iss 4, Pp 209-218 (2022)
Subject of the study The subject of the study is a price analysis of the limit groups of reimbursed beta-2 adrenergic drugs. Rationalisation of reimbursement expenditure, including generic substitution, is carried out in order to maximise health effe
Externí odkaz:
https://doaj.org/article/b3161979a7274b55b30138f2a20dba3b
Autor:
Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett, Arnold G. Vulto
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Background: From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the originator product may have influenced biosimilar entry.Objectives: The aim of thi
Externí odkaz:
https://doaj.org/article/91efa0738a404ac58954a5cf23bc3c10
Autor:
Marta Anczewska, Jolanta Janus, Piotr Gorczyca, Marek Balicki, Mariusz Zięba, Robert Plisko, Piotr Ścibior, Amelia Droździkowska, Sylwia Paciorek
Publikováno v:
Psychiatria Polska. 56:751-766
CelAnaliza praktyki preskrypcyjnej leków przeciwpsychotycznych w schizofrenii w latach 2013 - 2018.MetodaSchizofrenia jest analizowana jako jedna z pięciu chorób o najwyższym wskaźniku utraconych lat życia w zdrowiu - Disability Adjusted Life Y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34b369ce98ed7368e23f200d2ff0cc49
https://doi.org/10.12740/pp/onlinefirst/134082
https://doi.org/10.12740/pp/onlinefirst/134082
Autor:
Robert Plisko, Magdalena Władysiuk, Maciej Niewada, Michał Jachimowicz, Katarzyna Wepsięć, Cezary Pruszko, Michał Jakubczyk, Joanna Lis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051ab520987af7d3ec89ce5add42e0ef
https://ruj.uj.edu.pl/xmlui/handle/item/312329
https://ruj.uj.edu.pl/xmlui/handle/item/312329
Autor:
Wouter Hamelinck, Elita Poplavska, Ott Laius, Ruaraidh Hill, Jurij Fürst, Dzintars Gotham, Iva Selke Krulichová, Zornitza Mitkova, Ileana Mardare, Andrew F. Hill, Stuart McTaggart, Brian Godman, Corrine Zara, Vanda Marković-Peković, Patricia Vella Bonanno, Mark Parker, Caridad Pontes, Katarina Banasova, Tanja Novakovic, John Yfantopoulos, Janet Wale, Irene Langner, Hans Piepenbrink, Christian Hierländer, Peter Skiold, Guenka Petrova, Magdalene Wladysiuk, Amanj Kurdi, Vincent de Valk, Stephen Campbell, Anna Nachtnebel, Admir Malaj, Roberta Joppi, Angela Timoney, Maria Juhasz-Haverinen, Antony P. Martin, Jolanta Gulbinovič, Merce Obach Cortadellas, Iris Hoxha, Arianit Jakupi, Durhane Wong-Rieger, Catherine Sermet, D Tomek, Gisbert Selke, Eleonora Allocati, Ieva Greiciute-Kuprijanov, Tomasz Bochenek, Steven Simoens, Robert Plisko
Publikováno v:
University of Strathclyde
Introduction/Objectives: Health authorities are facing increasing challenges to the sustainability of their healthcare systems because of the growing expenditures on medicines, including new, high-priced oncology medicines, and changes in disease pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77151d4ac5e7399df29d92a7faac2a6
https://strathprints.strath.ac.uk/75033/1/Godman_etal_GABI_2021_Variation_in_the_prices_of_oncology_medicines_across_Europe.pdf
https://strathprints.strath.ac.uk/75033/1/Godman_etal_GABI_2021_Variation_in_the_prices_of_oncology_medicines_across_Europe.pdf
Autor:
Vasileios Kourafalos, Eleonora Allocati, Luka Voncina, Brian Godman, Arianit Jakupi, Robert Plisko, Evelien Moorkens, Kateřina Kohoutová, Nataša Grubiša, Gisbert Selke, Anita Viksna, Arnold G. Vulto, Jurij Fürst, Jaana E. Martikainen, Leona Popelková, Ileana Mardare, Patricia Vella Bonanno, Vincent Suttorp, Dorthe Bartels, Sarah Mörtenhuber, Ott Laius, Iris Hoxha, Gustaf Befrits, Isabelle Huys, Dmitry Meshkov, Gnosia Achniotou, Rannveig Einarsdóttir, Øyvind Melien, Juraj Slabý, Ieva Greičiūtė-Kuprijanov, Simon Keuerleber, Einar Magnusson, Corinne Zara, Admir Malaj, Robert Puckett, Silvia Stockinger, Vanda Marković-Peković, Maria Dimitrova, Vera Vlahović Palčevski, Konstantin Tachkov, Tanja Novakovic, Roisin Adams, Roberta Joppi
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, 11:591134. Frontiers Media S.A.
Frontiers in Pharmacology
Volume 11
Frontiers in Pharmacology, 11:591134. Frontiers Media S.A.
Frontiers in Pharmacology
Volume 11
Background: From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the originator product may have influenced biosimilar entry.Objectives: The aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faa4da2fb244fd6ae5a4663168b042ca
https://www.frontiersin.org/articles/10.3389/fphar.2020.591134/full
https://www.frontiersin.org/articles/10.3389/fphar.2020.591134/full
Autor:
Evelien, Moorkens, Brian, Godman, Isabelle, Huys, Iris, Hoxha, Admir, Malaj, Simon, Keuerleber, Silvia, Stockinger, Sarah, Mörtenhuber, Maria, Dimitrova, Konstantin, Tachkov, Luka, Vončina, Vera Vlahović, Palčevski, Gnosia, Achniotou, Juraj, Slabý, Leona, Popelková, Kateřina, Kohoutová, Dorthe, Bartels, Ott, Laius, Jaana E, Martikainen, Gisbert W, Selke, Vasileios, Kourafalos, Einar, Magnússon, Rannveig, Einarsdóttir, Roisín, Adams, Roberta, Joppi, Eleonora, Allocati, Arianit, Jakupi, Anita, Viksna, Ieva, Greičiūtė-Kuprijanov, Patricia, Vella Bonanno, Vincent, Suttorp, Øyvind, Melien, Robert, Plisko, Ileana, Mardare, Dmitry, Meshkov, Tanja, Novakovic, Jurij, Fürst, Corinne, Zara, Vanda, Marković-Peković, Nataša, Grubiša, Gustaf, Befrits, Robert, Puckett, Arnold G, Vulto
Publikováno v:
Frontiers in Pharmacology
Background: From October 2018, adalimumab biosimilars could enter the European market. However, in some countries, such as Netherlands, high discounts reported for the originator product may have influenced biosimilar entry. Objectives: The aim of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d8152979b218c4c2a189561dc041fcd
https://pubmed.ncbi.nlm.nih.gov/33519450
https://pubmed.ncbi.nlm.nih.gov/33519450
Autor:
Stuart McTaggart, Irene Langer, Ieva Greiciute-Kuprijanov, Patricia Vella Bonanno, Anne Marthe Ringerud, Angela Timoney, Jurij Fürst, John Yfantopoulos, Arianit Jakupi, Tatjana Ponorac, Robert Sauermann, Vanda Marković-Peković, Dzintars Gotham, D Tomek, Admir Malaj, Corinne Zara, Christian Hierländer, Peter Skiold, Vincent de Valk, Guenka Petrova, Antony P. Martin, JF (Hans) Piepenbrink, Jolanta Gulbinovič, Janet Wale, Iris Hoxha, Wouter Hamelinck, Maria Juhasz-Haverinen, Nataša Grubiša, Steven Simoens, Catherine Sermet, Ott Laius, Gisbert Selke, Robert Plisko, Celia C. Rothe, Tomasz Bochenek, Andrew F. Hill, Tanja Novakovic, Zornitza Mitkova, Ileana Mardare, Alan Haycox, Roberta Joppi, Carolin Hagen, Magdalene Wladysiuk, Amanj Kurdi, Elita Poplavska, Brian Godman, Merce Obach Cortadellas, Mark Parker
Publikováno v:
Generics and Biosimilars Initiative Journal
Introduction: There are appreciable concerns among European health authorities with growing expenditure on cancer medicines and issues of sustainability. The enhanced use of low cost generics could help. Aims: Consequently, there is a need to compreh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0009ea13d1e0e5433c3f43ffb8a0034b
https://ruj.uj.edu.pl/xmlui/handle/item/257394
https://ruj.uj.edu.pl/xmlui/handle/item/257394
Autor:
Karina, Jahnz-Różyk, Aleksandra, Kucharczyk, Marta, Warchoł, Anna, Radziwilska-Muc, Magdalena, Władysiuk, Robert, Plisko
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 39(230)
The costs incurred for treatment of patients with asthma are an important part of health care in the budget of each country. The aim of the study was to evaluate the direct and indirect costs of asthma in Poland. The study was based on questionnaires
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2843910c43b05ace690731b168a8f69d
https://pubmed.ncbi.nlm.nih.gov/26319382
https://pubmed.ncbi.nlm.nih.gov/26319382
Autor:
Robert Plisko, Magdalena Władysiuk, Anita Stożek, Przemysław Ryś, Marek Kokot, Piotr Wojciechowski, Agnieszka Rogóż
Publikováno v:
A31. OPTIMIZING THERAPEUTIC STRATEGIES IN AIRWAYS DISEASE.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::695648c043d5ee8fda88a448f1608074
https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1297
https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1297